T
Thomas Knoop
Researcher at University of Bergen
Publications - 16
Citations - 118
Thomas Knoop is an academic researcher from University of Bergen. The author has contributed to research in topics: Nephropathy & Medicine. The author has an hindex of 4, co-authored 8 publications receiving 91 citations. Previous affiliations of Thomas Knoop include Haukeland University Hospital.
Papers
More filters
Journal ArticleDOI
Mortality in patients with IgA nephropathy.
Thomas Knoop,Thomas Knoop,Bjørn Egil Vikse,Einar Svarstad,Einar Svarstad,Sabine Leh,Sabine Leh,Anna Varberg Reisæter,Rune Bjørneklett,Rune Bjørneklett +9 more
TL;DR: Mortality in patients with IgAN was twice the expected rate, but not significantly increased before RRT, and the risk of end-stage renal disease was substantially higher than risk of death.
Journal ArticleDOI
Long-term outcome in 145 patients with assumed benign immunoglobulin A nephropathy.
Thomas Knoop,Thomas Knoop,Bjørn Egil Vikse,Angela Mwakimonga,Sabine Leh,Rune Bjørneklett,Rune Bjørneklett +6 more
TL;DR: It is shown that 18.6% of patients with assumed benign IgAN had progressive disease after a median duration of 22 years and that these patients could not be predicted at the time of biopsy, demonstrating that an extended follow-up period is needed when assessing prognosis in this group of patients.
Journal ArticleDOI
Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
Thomas Knoop,Ann Merethe Vågane,Bjørn Egil Vikse,Einar Svarstad,Bergrun Tinna Magnusdottir,Sabine Leh,Anna Varberg Reisæter,Rune Bjørneklett +7 more
TL;DR: The ARR model significantly stratified the IgAN cohort according to risk of ESRD/death and substantially improved its accuracy in a nationwide cohort of IgAN patients.
Journal ArticleDOI
Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies
Sanjeevan Sriskandarajah,Knut Aasarød,Steinar Skrede,Thomas Knoop,Anna Varberg Reisæter,Rune Bjørneklett +5 more
TL;DR: In Norwegian patients with ANCA-associated glomerulonephritis, prognosis was significantly better in 2003–12 compared with 1988–2002, probably partly due to a shorter diagnostic delay, and better therapeutic management in older patients.
Journal ArticleDOI
Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up
TL;DR: The International IgAN Prediction Tool was well calibrated, while the IgA Nephropathy Clinical Decision Support System tends to underestimate risk for patients with higher risk, and overestimates risk in the lower risk categories.